Triple-Negative Breast Cancer: Latasha’s Story

Latasha Jordan, a triple-negative breast cancer survivor, discusses challenges she faced with her symptoms and diagnosis, and Aditya Bardia, M.D., MPH, reviews the typical diagnostic work-up used to determine a treatment approach.

Latasha Jordan discusses her experience with neoadjuvant chemotherapy, and an expert in the management of breast cancer, Aditya Bardia, M.D., MPH, reviews common side events associated with systemic treatment.

Aditya Bardia, M.D., MPH, and triple-negative breast cancer survivor, Latasha Jordan, discuss the importance of shared decision-making when considering mastectomy or lumpectomy and radiation for triple-negative breast cancer.

A leader in breast oncology and a triple-negative breast cancer survivor discuss the role of active surveillance for post-surgical disease progression and emphasize the importance of support from health care providers after recurrence.

A patient with triple-negative breast cancer, Latasha Jordan, reflects on the mental and emotional challenges she faced when she learned of her disease progression and shares her positive experience with physician referral thereafter.

An expert oncologist highlights the importance of discussing clinical trial options with patients and comments on the recent FDA approval of sacituzumab govitecan in triple-negative breast cancer based on the ASCENT 3 trial.

Latasha Jordan discusses her experience in a clinical trial with sacituzumab govitecan and comments on the side effects she experienced as well as the overall impact on her quality of life.

A triple-negative breast cancer (TNBC) survivor, Latasha Jordan, considers the positive impact her support network has had on her treatment; and Aditya Bardia, M.D., MPH, emphasizes the importance of social support systems for patients with TNBC.

Latasha Jordan and Aditya Bardia, M.D., MPH, share advice for patients and caregivers on the importance of a positive outlook and attitude when living with triple-negative breast cancer.